M&A Deal Summary |
|
|---|---|
| Date | 2022-05-26 |
| Target | Aalto Bio Reagents |
| Sector | Life Science |
| Buyer(s) | Biosynth |
| Deal Type | Add-on Acquisition |
SEARCH BY
Biosynth is a fully hybrid research products, life sciences reagents and custom synthesis and manufacturing services company with global research, manufacturing and distribution facilities. They are the supplier of choice for many in the pharmaceutical, life science, food, agrochemical, cosmetic and diagnostic sectors and manufacture and source a vast range of chemical and biochemical products. Biosynth was formed in 1965 and is based in St. Gallen, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 8 |
| Sector: Life Science M&A | 3 of 7 |
| Type: Add-on Acquisition M&A Deals | 3 of 8 |
| Country: Ireland M&A | 1 of 1 |
| Year: 2022 M&A | 3 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-03-17 |
vivitide
Gardner, Massachusetts, United States vivitide is a provider of custom peptide synthesis services, custom antibodies, catalog peptides, and biochemicals to academia, pharmaceutical, biotech, and diagnostic companies worldwide. vivitide was founded in 1998 and is based in Gardner, Massachusetts. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-06-30 |
Pepscan
Lelystad, Netherlands Pepscan engages in developing and applying peptide expertise to support customers in peptide discovery, development and production. From its end-to-end facility in Lelystad, Pepscan offers a range of proprietary technologies, phage display capabilities, a lead optimization array platform and manufacturing facilities for R&D into GMP peptides, including libraries and neo-antigen vaccines. The patents include CLIPS™ technology, which can be used to fix peptides in their active, binding structures. Pepscan is based in Lelystad, Netherlands. |
Buy | - |
